Skip to main content

ORCRY · Organo Corporation · Financials

Track ORCRY — free
$14.50 At close · Oct 23 Q1 2026 earnings call transcript
Market Cap
$3.33B
Shares
229.91M
Volume · Oct 23 100 Avg daily vol (3 sessions) 700

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Revenue
177.65B +8.8%
FY2026 Revenue FY2022–FY2026
Net Income
28.4B +17.6%
FY2026 Net Income FY2022–FY2026
Gross Margin
36.64% +2.8pp
FY2026 Gross Margin FY2022–FY2026
Operating Margin
21.19% +2.1pp
FY2026 Operating Margin FY2022–FY2026
Operating Cash Flow
13.1B -37.9%
FY2026 Operating Cash Flow FY2022–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2026 FY2025 FY2024 FY2023 FY2022
JPY 177.65B 163.27B 150.36B 132.43B 112.07B
JPY 112.57B 108.09B 106.51B 97.45B 83.56B
JPY 65.08B 55.18B 43.84B 34.98B 28.51B
JPY 37.65B 31.12B 22.54B 15.21B 10.85B
JPY 38.31B 32.36B 23.63B 16.04B 12.7B
JPY 9.91B 8.17B 6.3B 4.27B 3.47B
JPY 28.4B 24.15B 17.31B 11.73B 9.21B
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 21.83B in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.

Key facts CIK 2142762 CUSIP 68590A100 Visit website Investor relations